Research Management Committee

INDEPENDENT. INTERNATIONAL. LEADERS.

 

The Research Management Committee (RMC) is made up of independent members whose primary role is to evaluate research proposals and actively help BioCanRx monitor the progress of its projects. The RMC will build and maintain a robust, competitive research portfolio founded on scientific excellence and network goals. All RMC funding and budget recommendations go to the Board of Directors for approval.

 

In order to avoid potential conflicts of interest, the voting RMC is composed of independent and primarily international experts in biotherapeutics.

 

Membership

 

stephanrussell-1
seet190
grantmcfadden-1
len-seymour
Dr. Stephen Russell
Professor, Molecular Medicine
Consultant, Hematology
Mayo Clinic (USA)
Dr. Bruce Seet
Director, Medical Affairs, Sanofi-Pasteur (Canada)
Dr. Grant McFadden
Director, Center for Immunotherapy, Vaccines, and Virotherapy Biodesign Institute, Arizona State U, Tempe, AZ (USA)
Dr. Len Seymour
Founder and Chief Scientific Officer, Oxford Genetics (UK)
alanmelcher-1
iramellman-1
clionarooney-1
chrisklebanoff-1
Dr. Alan Melcher
Professor of Translational Immunotherapy, The Institute of Cancer Research, Chester Beatty Laboratories, London (UK)
Dr. Ira Mellman
Vice-President, Cancer Immunology, Genentech (USA)
Dr. Cliona Rooney
Professor, Baylor College of Medicine (USA)
Dr. Chris Klebanoff
Assistant Clinical Investigator, NCI Surgery Branch, NIH (USA)
robertcoffin-2
stevexanthoudakis-1
jhoch
nonetto
Dr. Robert Coffin
Entrepreneur & Founder, BioVex (USA)
Dr. Steven Xanthoudakis
Director, Licensing and External Research, Merck Research Laboratories (Canada)
Dr. Jeffrey Hoch
Professor, Department of Public Health Sciences, UC Davis
Dr. Nicole Onetto
Former Deputy Director and Chief Scientific Officer, Ontario Institute for Cancer Research (Canada)
kchan
smandrekar
Dr. Kelvin Chan
Associate Scientist, Sunnybrook Health Sciences Centre (Canada)
Dr. Sumithra Mandrekar
Professor of Biostatistics and Oncology at the Mayo Clinic (USA)

 

EX-OFFICIO MEMBERS (NON-VOTING)

 

Dr. John Bell
BioCanRx Scientific Director
Senior Scientist, the Ottawa Hospital Research Institute
Professor, uOttawa

 

Dr. Brian Lichty
BioCanRx Theme Leader
Associate Professor, Pathology and Molecular Medicine, McMaster University

 

Dr. Jason Moffat
BioCanRx Theme Leader
Associate Professor, Canada Research Chair in Functional Genomics of Cancer, University of Toronto

 

Dr. Brad Nelson
BioCanRx Theme Leader
Director and Distinguished Scientist, Deeley Research Centre, BCCA
Professor, Biochemistry and Microbiology, University of Victoria

 

Dr. Claude Perreault
Principal Investigator, IRIC
Professor, Faulty of Medicine, Université de Montréal
Hematologist, Maisonneuve-Rosemont Hospital

 

 

OBSERVERS

 

Dr. Stéphanie Michaud
President and CEO, BioCanRx

 

Dr. Kelley Parato
Director, Scientific Affairs, BioCanRx

 

Kimberly Douglas
Senior Program Manager, Networks of Centres of Excellence